A Nurse-Led Demonstration Efficacy With Tailored Mobile Application For Skill Development In Self-Administration Of Insulin Therapy Among Type-II Diabetes Patients

Abstract

Background: Diabetes mellitus (DM) is one of the most prevalent public health concerns globally. It is a disorder of carbohydrate metabolism in which blood glucose level is chronically high due to insulin's impaired secretion or action. It has two types: type I, which occurs in childhood and is usually mediated by immune mechanisms, and type II, which occurs later in life, particularly with advancing age due to diseases of the pancreas. A significant portion, accounting for 60% of the patient population performing self-administration of insulin incorrectly

Objective: To assess nurse-led demonstration efficacy with tailored mobile application for skill development in self-administration of insulin therapy among Type-II diabetes mellitus patients.

Methodology: A single group pretest-posttest quasi-experimental study design was used in this investigation. The sample size consisted of 88 Type II Diabetic patients using a nonprobability purposive sampling technique. A validated technique was used to assess the effectiveness of the nurse-led demonstration efficacy with adapted mobile application for skill development program, as well as the self-administration of insulin therapy among Type-II diabetes mellitus patients before and after. The study participants' baseline self-administration of insulin therapy scores were initially obtained through pre-assessment. The selected participants were subsequently provided with two months of workshop-style interventional sessions, and post-intervention data were collected.

Results: The intervention had a considerable impact on the mean efficacy level, according to the study's findings. It was 10.53 with a standard deviation (SD) of 3.997 prior to the intervention, showing a comparatively low level of proficiency in insulin self-demonstration. A week after the intervention, the mean climbed dramatically to 25.84 with an SD of 2.425, indicating a considerable improvement in performance and more consistent results across participants. Shortly after the intervention, the mean increased significantly to 23.28 with a lower SD of 3.366. With a P-value of.000 and a t-value of -28.424 and -36.202, it was determined that the increase in insulin demonstration efficacy was statistically significant.

Conclusion: It is concluded that the nurse-led demonstration efficacy with tailored mobile application program has positive effect on self-administration of insulin therapy among Type-II diabetes mellitus patients